Search

shutterstock_2261453831(1) (1)

Announcements

Announcements

HOMEWhat’s NewAnnouncements

2024.Jun.19

Announcement on behalf of OBIGEN of important resolutions of 2024 Annual Shareholders’ meeting and accumulated losses amounting to 50% of paid-in capital

2024.Jun.17

Announcement of 2024 Annual General Shareholders' meeting’s resolution to lift the non-competition restrictions for directors

2024.Jun.17

Announcement of the Company’s important resolutions of the 2024 Annual General Shareholders’ meeting.

2024.Jun.17

OBI-992 TROP2 ADC has been granted by TFDA to proceed to Phase I/II human clinical trial

2024.May.30

OBI has filed the application of a Phase I/II human clinical trial for OBI-992 TROP2 ADC to TFDA

2024.May.30

Announcement on behalf of Amaran that the Company’s Board of Directors resolved to appoint Ms. Tessie Che as Chairperson

2024.May.29

Announcement on behalf of Amaran of re-election of directors and supervisors at the 2024 Annual General Shareholders’ meeting

2024.May.29

Announcement on behalf of Amaran of resolution to lift the non-competition restrictions for new directors

2024.May.29

Announcement on behalf of Amaran of important resolutions at the 2024 Annual General Shareholders’ meeting.

2024.May.10

OBI announces the termination of license agreement with Odeon for the rights of OBI-999 and OBI-833 in China, Hong Kong and Macau

News

Latest News

Events

Latest events